ideasIdea
Plain-language trial results returned to every participant within a year
If you join a cancer trial you should be told what it found, in plain words, within twelve months of the results, including if the treatment did not work.
Most trial participants never learn the results. The EU Clinical Trials Regulation requires lay summaries; enforcement and quality are patchy, and most other jurisdictions have no requirement. The proposal is a global norm: lay summary within 12 months of primary completion, delivered directly to participants, with negative results treated identically, and posting in registries as a condition of publication.
Hypothesis
Returning results increases willingness to enrol in future trials among participants and their networks and increases timely reporting of negative trials.
Rationale
Reciprocity is the moral basis of research participation; participants who receive results are more likely to recommend trials, and the requirement creates a deadline that also forces disclosure of negative findings.
What would test it
Compare enrolment attitudes and re-participation in cohorts who did and did not receive summaries; audit registry completeness where the rule is enforced versus not.
Maturity
being tested at scale
Who has to act
regulator
Cost to try
Small (under $1M)
Years to first evidence
2
Bottlenecks it attacks
- Patients lack understanding, navigation and agency · Most patients cannot understand their options, find trials, or push back, so decisions are made for them.
- Failures are hidden · Negative trials, failed drugs and abandoned programmes are rarely published, so the same mistakes are repeated.